The report provides an overview of cancer prevalence, treatment patterns, and survival statistics in the United States as of January 1, 2022. It highlights the increasing number of cancer survivors due to population growth, aging, and advancements in early detection and treatment. The American Cancer Society and the National Cancer Institute collaborate to estimate cancer prevalence using data from various sources, including cancer registries, vital statistics, and population projections. Key findings include: - Over 18 million Americans with a history of cancer were alive in 2022, with more than half diagnosed within the past 10 years. - The most prevalent cancers are prostate (3,523,230 cases), melanoma of the skin (760,640 cases), and colon and rectum (726,450 cases) among males, and breast (4,055,770 cases), uterine corpus (891,560 cases), and thyroid (823,800 cases) among females. - Racial disparities exist in treatment, particularly for rectal cancer and non-small cell lung cancer, with Black patients receiving less favorable treatments compared to White patients. - Treatment options and survival rates vary by cancer type, with advancements in early detection and treatment improving overall survival rates. - Long-term health effects of cancer treatment include physical impairments, sexual dysfunction, and cognitive impairment, which can significantly impact survivors' quality of life. The report emphasizes the need for evidence-based strategies and equitable access to resources to address disparities and optimize care for cancer survivors.The report provides an overview of cancer prevalence, treatment patterns, and survival statistics in the United States as of January 1, 2022. It highlights the increasing number of cancer survivors due to population growth, aging, and advancements in early detection and treatment. The American Cancer Society and the National Cancer Institute collaborate to estimate cancer prevalence using data from various sources, including cancer registries, vital statistics, and population projections. Key findings include: - Over 18 million Americans with a history of cancer were alive in 2022, with more than half diagnosed within the past 10 years. - The most prevalent cancers are prostate (3,523,230 cases), melanoma of the skin (760,640 cases), and colon and rectum (726,450 cases) among males, and breast (4,055,770 cases), uterine corpus (891,560 cases), and thyroid (823,800 cases) among females. - Racial disparities exist in treatment, particularly for rectal cancer and non-small cell lung cancer, with Black patients receiving less favorable treatments compared to White patients. - Treatment options and survival rates vary by cancer type, with advancements in early detection and treatment improving overall survival rates. - Long-term health effects of cancer treatment include physical impairments, sexual dysfunction, and cognitive impairment, which can significantly impact survivors' quality of life. The report emphasizes the need for evidence-based strategies and equitable access to resources to address disparities and optimize care for cancer survivors.